• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ABCC1的过表达赋予了对桦木醇的耐药性。

Overexpression of ABCC1 Confers Drug Resistance to Betulin.

作者信息

Chen Xuan-Yu, Yang Yuqi, Wang Jing-Quan, Wu Zhuo-Xun, Li Jing, Chen Zhe-Sheng

机构信息

College of Integrated Chinese and Western Medicine, Hebei Medical University, Shijiazhuang, China.

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, New York, NY, United States.

出版信息

Front Oncol. 2021 Feb 25;11:640656. doi: 10.3389/fonc.2021.640656. eCollection 2021.

DOI:10.3389/fonc.2021.640656
PMID:33718236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7951056/
Abstract

Betulin is a lupane-type pentacyclic triterpene, which is isolated from birch bark. It has a broad spectrum of biological and pharmacological properties, such as anti-inflammatory, anti-tumor, anti-viral, and anti-bacterial activity. Herein, we explored the factors that may result in betulin resistance, especially with respect to its interaction with ATP-binding cassette subfamily C member 1 (ABCC1). ABCC1 is an important member of the ATP-binding cassette (ABC) transporter family, which is central to mediating multidrug resistance (MDR) in naturally derived anticancer agents. An MTT-based cell viability assay showed that ABCC1 overexpression has the ability to desensitize both cancer cell line and gene-transfected cell line to betulin and that this betulin-induced resistance can be antagonized by a known ABCC1 inhibitor MK571 at 25 μM. Additionally, betulin upregulates the ABCC1 protein expression level in both concentration-dependent and time-dependent manners, also blocks the transport function mediated by ABCC1. Subsequently, a high affinity score of betulin was achieved in a computational docking analysis, demonstrating a strong interaction of betulin with ABCC1.

摘要

桦木醇是一种羽扇豆烷型五环三萜,从白桦树皮中分离得到。它具有广泛的生物学和药理学特性,如抗炎、抗肿瘤、抗病毒和抗菌活性。在此,我们探讨了可能导致桦木醇耐药的因素,特别是其与ATP结合盒亚家族C成员1(ABCC1)的相互作用。ABCC1是ATP结合盒(ABC)转运蛋白家族的重要成员,在介导天然来源抗癌药物的多药耐药(MDR)中起核心作用。基于MTT的细胞活力测定表明,ABCC1过表达能够使癌细胞系和基因转染细胞系对桦木醇脱敏,并且这种桦木醇诱导的耐药性可被25μM的已知ABCC1抑制剂MK571拮抗。此外,桦木醇以浓度依赖性和时间依赖性方式上调ABCC1蛋白表达水平,还阻断ABCC1介导的转运功能。随后,在计算对接分析中获得了桦木醇的高亲和力评分,表明桦木醇与ABCC1有强烈相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66b/7951056/f0d5c3974007/fonc-11-640656-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66b/7951056/1eb8046ce2b9/fonc-11-640656-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66b/7951056/238f313734f8/fonc-11-640656-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66b/7951056/f0d5c3974007/fonc-11-640656-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66b/7951056/1eb8046ce2b9/fonc-11-640656-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66b/7951056/238f313734f8/fonc-11-640656-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66b/7951056/f0d5c3974007/fonc-11-640656-g003.jpg

相似文献

1
Overexpression of ABCC1 Confers Drug Resistance to Betulin.ABCC1的过表达赋予了对桦木醇的耐药性。
Front Oncol. 2021 Feb 25;11:640656. doi: 10.3389/fonc.2021.640656. eCollection 2021.
2
Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.姜黄素的主要代谢产物四氢姜黄素对三种ABC药物转运蛋白,即P-糖蛋白(ABCB1)、米托蒽醌耐药蛋白(ABCG2)和多药耐药蛋白1(ABCC1)功能的调节作用。
Mol Cell Biochem. 2007 Feb;296(1-2):85-95. doi: 10.1007/s11010-006-9302-8. Epub 2006 Sep 8.
3
Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1).人多药耐药蛋白 1(MRP1/ABCC1)的结构和功能特性。
Curr Med Chem. 2011;18(3):439-81. doi: 10.2174/092986711794839197.
4
C-phycocyanin to overcome the multidrug resistance phenotype in human erythroleukemias with or without interaction with ABC transporters.藻蓝蛋白克服人红白血病多药耐药表型,无论有无 ABC 转运蛋白的相互作用。
Biomed Pharmacother. 2018 Oct;106:532-542. doi: 10.1016/j.biopha.2018.06.145. Epub 2018 Jul 11.
5
Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1).吡咯嘧啶衍生物和嘌呤类似物作为多药耐药相关蛋白 1(MRP1,ABCC1)的新型激活剂。
Biochim Biophys Acta Biomembr. 2017 Jan;1859(1):69-79. doi: 10.1016/j.bbamem.2016.10.017. Epub 2016 Oct 31.
6
Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.达可替尼通过抑制 ABCB1 和 ABCG2 转运蛋白的外排活性来拮抗癌细胞中的多药耐药(MDR)。
Cancer Lett. 2018 May 1;421:186-198. doi: 10.1016/j.canlet.2018.01.021. Epub 2018 Jan 11.
7
Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agents.阿霉素作为荧光报告物鉴定新型 MRP1(ABCC1)抑制剂,这些抑制剂在基于 calcein 的抗癌药物高通量筛选中被遗漏。
Biomed Pharmacother. 2019 Oct;118:109289. doi: 10.1016/j.biopha.2019.109289. Epub 2019 Aug 8.
8
3β-Acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity.3β-乙酰 tormentic 酸通过调节细胞内谷胱甘肽水平和抑制谷胱甘肽 S-转移酶活性逆转 MRP1/ABCC1 介导的癌症耐药性。
Eur J Pharmacol. 2014 Oct 15;741:140-9. doi: 10.1016/j.ejphar.2014.07.054. Epub 2014 Aug 9.
9
Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.人癌细胞系、多药耐药细胞模型以及乳腺癌患者的肿瘤、肿瘤旁和肿瘤远处组织中ABCB1、ABCC1和ABCG2的启动子甲基化模式。
Oncotarget. 2016 Nov 8;7(45):73347-73369. doi: 10.18632/oncotarget.12332.
10
Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.通关藤及其主要活性成分多氧孕甾烷逆转多药耐药性
J Ethnopharmacol. 2017 May 5;203:110-119. doi: 10.1016/j.jep.2017.03.051. Epub 2017 Mar 28.

引用本文的文献

1
ABCC1 and ABCC10 as predictive biomarkers of docetaxel treatment response in prostate cancer.ABCC1和ABCC10作为前列腺癌多西他赛治疗反应的预测生物标志物。
Curr Res Pharmacol Drug Discov. 2025 Mar 14;8:100216. doi: 10.1016/j.crphar.2025.100216. eCollection 2025.
2
Oestrogen receptor positive breast cancer and its embedded mechanism: breast cancer resistance to conventional drugs and related therapies, a review.雌激素受体阳性乳腺癌及其内在机制:乳腺癌对常规药物和相关疗法的耐药性,综述。
Open Biol. 2024 Jun;14(6):230272. doi: 10.1098/rsob.230272. Epub 2024 Jun 19.
3
Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cells.

本文引用的文献

1
Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor.调控 ABCB1 功能:酪氨酸激酶抑制剂西他拉奈的体外和体内特征。
Cancer Commun (Lond). 2020 Jul;40(7):285-300. doi: 10.1002/cac2.12040. Epub 2020 Jun 11.
2
Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells .西曲替尼,一种酪氨酸激酶抑制剂,可抑制ABCG2的转运功能并恢复对化疗耐药癌细胞的敏感性。
Front Oncol. 2020 May 12;10:700. doi: 10.3389/fonc.2020.00700. eCollection 2020.
3
Lung Cancer Inhibition by Betulinic Acid Nanoparticles via Adenosine 5'-Triphosphate (ATP)-Binding Cassette Transporter G1 Gene Downregulation.
多药耐药转运蛋白P-糖蛋白(P-gp)和乳腺癌耐药蛋白(BCRP)限制了ATR抑制剂西拉瑞利在癌细胞中的疗效。
Front Pharmacol. 2024 May 2;15:1400699. doi: 10.3389/fphar.2024.1400699. eCollection 2024.
4
The impact of agrochemical pollutant mixtures on the selection of insecticide resistance in the malaria vector Anopheles gambiae: insights from experimental evolution and transcriptomics.农药污染物混合物对疟疾传播媒介按蚊抗药性选择的影响:来自实验进化和转录组学的见解。
Malar J. 2024 Mar 5;23(1):69. doi: 10.1186/s12936-023-04791-0.
5
Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy.肿瘤发生发展中的癌胚重编程:癌症治疗的新见解
MedComm (2020). 2023 Dec 2;4(6):e427. doi: 10.1002/mco2.427. eCollection 2023 Dec.
6
Editorial: Chemo-Radiation-Resistance in Cancer Therapy.社论:癌症治疗中的放化疗耐药性
Front Pharmacol. 2022 May 18;13:904063. doi: 10.3389/fphar.2022.904063. eCollection 2022.
7
MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: and study.MET抑制剂替泊替尼可拮抗由ABCG2转运蛋白介导的多药耐药性:一项研究。
Acta Pharm Sin B. 2022 May;12(5):2609-2618. doi: 10.1016/j.apsb.2021.12.018. Epub 2021 Dec 30.
8
The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter.癌细胞对细胞周期蛋白依赖性激酶4/6抑制剂帕博西尼的耐药性由ABCB1转运蛋白介导。
Front Pharmacol. 2022 Mar 8;13:861642. doi: 10.3389/fphar.2022.861642. eCollection 2022.
9
Chinese Medicine Formula Siwu-Yin Inhibits Esophageal Precancerous Lesions by Improving Intestinal Flora and Macrophage Polarization.中药方剂四物汤通过改善肠道菌群和巨噬细胞极化抑制食管前病变。
Front Pharmacol. 2022 Mar 3;13:812386. doi: 10.3389/fphar.2022.812386. eCollection 2022.
10
ABCB1 limits the cytotoxic activity of TAK-243, an inhibitor of the ubiquitin-activating enzyme UBA1.ABCB1 限制了泛素激活酶 UBA1 抑制剂 TAK-243 的细胞毒性活性。
Front Biosci (Landmark Ed). 2022 Jan 5;27(1):5. doi: 10.31083/j.fbl2701005.
白桦脂酸纳米粒通过下调三磷酸腺苷结合盒转运蛋白 G1 基因抑制肺癌。
Med Sci Monit. 2020 Apr 11;26:e922092. doi: 10.12659/MSM.922092.
4
Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells.维奈托克,一种BCL-2抑制剂,可增强化疗药物在野生型ABCG2过表达介导的多药耐药癌细胞中的疗效。
Cancers (Basel). 2020 Feb 18;12(2):466. doi: 10.3390/cancers12020466.
5
Alkaloids as Anticancer Agents: A Review of Chinese Patents in Recent 5 Years.生物碱类抗癌药物:近 5 年中国专利分析。
Recent Pat Anticancer Drug Discov. 2020;15(1):2-13. doi: 10.2174/1574892815666200131120618.
6
Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance.替凡替尼,一种处于临床试验阶段的c-Met抑制剂,易受ABCG2介导的耐药性影响。
Cancers (Basel). 2020 Jan 12;12(1):186. doi: 10.3390/cancers12010186.
7
Reversible inhibition of efflux transporters by hydrogel microdevices.水凝胶微器件对外排转运蛋白的可逆抑制。
Eur J Pharm Biopharm. 2019 Dec;145:76-84. doi: 10.1016/j.ejpb.2019.10.007. Epub 2019 Oct 19.
8
Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer.生物活性化合物:预防和治疗乳腺癌的多靶点“银弹”
Cancers (Basel). 2019 Oct 15;11(10):1563. doi: 10.3390/cancers11101563.
9
Betulin and its derivatives as novel compounds with different pharmacological effects.白桦脂醇及其衍生物作为具有不同药理作用的新型化合物。
Biotechnol Adv. 2020 Jan-Feb;38:107409. doi: 10.1016/j.biotechadv.2019.06.008. Epub 2019 Jun 18.
10
Post-translational modifications and chromatin dynamics.翻译后修饰和染色质动力学。
Essays Biochem. 2019 Apr 23;63(1):89-96. doi: 10.1042/EBC20180067.